Histone Methyltransferase

Histone Methyltransferase Related Products (70):

By Effects:	Inhibitors (66) Antagonists (4)

Cat. No.	Product Name	Effect	Purity

HY-13470

GSK126 Inhibitor 99.86%

GSK126 is a potent, highly selective inhibitor of EZH2 methyltransferase with an IC₅₀ of 9.9 nM.
HY-13803

EPZ-6438 Inhibitor 99.63%

EPZ-6438 (Tazemetostat) is a potent, selective and orally available EZH2 inhibitor with K_i and IC₅₀ of 2.5 and 11 nM, respectively.
HY-13980

UNC0642 Inhibitor 99.81%

UNC0642 is a potent and selective G9a/GLP inhibitor, with an IC₅₀ of less than 2.5 nM.
HY-13500

GSK343 Inhibitor 98.49%

GSK343 is a highly potent and selective EZH2 inhibitor with an IC₅₀ of 4 nM.
HY-15593

EPZ-5676 Inhibitor 99.75%

EPZ-5676 is a potent DOT1L histone methyltransferase inhibitor with a K_i of 80 pM.
HY-104009A

GSK2807 Trifluoroacetate Inhibitor

GSK2807 Trifluoroacetate is a potent, selective and SAM-competitive inhibitor of SMYD3, with a K_i of 14 nM.
HY-19563

A-893 Inhibitor

A-893 is a cell-active inhibitor of Methyltransferase SMYD2, with an IC₅₀ of 2.8 nM.
HY-111390

Dot1L-IN-2 Inhibitor

Dot1L-IN-2 is a potent, selective and orally bioavailable inhibitor of Dot1L (a histone methyltransferase), with an IC₅₀ and K_i of 0.4 nM and 0.08 nM, respectively.
HY-12186

3-Deazaneplanocin A hydrochloride Inhibitor 99.76%

3-Deazaneplanocin A hydrochloride is a potent histone methyltransferase EZH2 inhibitor.
HY-15646

UNC1999 Inhibitor 99.47%

UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH1/2 with IC₅₀s of 10 nM and 45 nM, repectively.
HY-19324

EPZ031686 Inhibitor 99.63%

EPZ031686 is an orally available SMYD3 inhibitor with an IC₅₀ of 3 nM in cell-free assay.
HY-101563

GSK3326595 Inhibitor 99.24%

GSK3326595 is a potent, selective, reversible inhibitor of protein arginine methyltransferase 5 (PRMT5) with an IC₅₀ of 6.2 nM.
HY-15226A

AZ505 ditrifluoroacetate Inhibitor 99.99%

AZ505 ditrifluoroacetate is a potent and selective SMYD2 inhibitor with IC₅₀ of 0.12 μM.
HY-15227

EPZ004777 Inhibitor 99.89%

EPZ004777 is a potent, selective DOT1L inhibitor with an IC₅₀ of 0.4 nM.
HY-12727

EPZ015666 Inhibitor 98.56%

EPZ015666 is an orally available inhibitor of PRMT5 with an IC₅₀ of 22 nM.
HY-19615

MS023 Inhibitor 99.84%

MS023 is a potent, selective, and cell-active inhibitor of human type I PRMTs with IC50 of 4-119 nM.
HY-10587

BIX-01294 Inhibitor 98.61%

BIX-01294 is an inhibitor of G9a Histone Methyltransferase with IC₅₀ of 1.9 μM.
HY-100235

EPZ015866 Inhibitor 98.71%

EPZ015866 is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC₅₀ of 22 nM.
HY-19313

LLY-507 Inhibitor 99.09%

LLY-507 is a potent and selective inhibitor of protein-lysine methyltransferase SMYD2 with an IC₅₀ of 15 nM.

GSK126	Inhibitor	99.86%
GSK126 is a potent, highly selective inhibitor of EZH2 methyltransferase with an IC₅₀ of 9.9 nM.

EPZ-6438	Inhibitor	99.63%
EPZ-6438 (Tazemetostat) is a potent, selective and orally available EZH2 inhibitor with K_i and IC₅₀ of 2.5 and 11 nM, respectively.

UNC0642	Inhibitor	99.81%
UNC0642 is a potent and selective G9a/GLP inhibitor, with an IC₅₀ of less than 2.5 nM.

GSK343	Inhibitor	98.49%
GSK343 is a highly potent and selective EZH2 inhibitor with an IC₅₀ of 4 nM.

EPZ-5676	Inhibitor	99.75%
EPZ-5676 is a potent DOT1L histone methyltransferase inhibitor with a K_i of 80 pM.

GSK2807 Trifluoroacetate	Inhibitor
GSK2807 Trifluoroacetate is a potent, selective and SAM-competitive inhibitor of SMYD3, with a K_i of 14 nM.

A-893	Inhibitor
A-893 is a cell-active inhibitor of Methyltransferase SMYD2, with an IC₅₀ of 2.8 nM.

Dot1L-IN-2	Inhibitor
Dot1L-IN-2 is a potent, selective and orally bioavailable inhibitor of Dot1L (a histone methyltransferase), with an IC₅₀ and K_i of 0.4 nM and 0.08 nM, respectively.

3-Deazaneplanocin A hydrochloride	Inhibitor	99.76%
3-Deazaneplanocin A hydrochloride is a potent histone methyltransferase EZH2 inhibitor.

UNC1999	Inhibitor	99.47%
UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH1/2 with IC₅₀s of 10 nM and 45 nM, repectively.

EPZ031686	Inhibitor	99.63%
EPZ031686 is an orally available SMYD3 inhibitor with an IC₅₀ of 3 nM in cell-free assay.

GSK3326595	Inhibitor	99.24%
GSK3326595 is a potent, selective, reversible inhibitor of protein arginine methyltransferase 5 (PRMT5) with an IC₅₀ of 6.2 nM.

AZ505 ditrifluoroacetate	Inhibitor	99.99%
AZ505 ditrifluoroacetate is a potent and selective SMYD2 inhibitor with IC₅₀ of 0.12 μM.

EPZ004777	Inhibitor	99.89%
EPZ004777 is a potent, selective DOT1L inhibitor with an IC₅₀ of 0.4 nM.

EPZ015666	Inhibitor	98.56%
EPZ015666 is an orally available inhibitor of PRMT5 with an IC₅₀ of 22 nM.

MS023	Inhibitor	99.84%
MS023 is a potent, selective, and cell-active inhibitor of human type I PRMTs with IC50 of 4-119 nM.

BIX-01294	Inhibitor	98.61%
BIX-01294 is an inhibitor of G9a Histone Methyltransferase with IC₅₀ of 1.9 μM.

EPZ015866	Inhibitor	98.71%
EPZ015866 is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC₅₀ of 22 nM.

LLY-507	Inhibitor	99.09%
LLY-507 is a potent and selective inhibitor of protein-lysine methyltransferase SMYD2 with an IC₅₀ of 15 nM.

HY-N2019

Chaetocin	Inhibitor	>98.0%
Chaetocin is a specific inhibitor of the histone methyltransferase (HMT) SU(VAR)3-9 with an IC₅₀ of 0.6 μM for SU(VAR)3-9. It also inhibits thioredoxin reductase (TrxR) with an IC₅₀ of 4 μM.

Name
Email *

	Sorry, but the email address you supplied was invalid.